1-3 of 3
Tetsumi Yoshida, MD
Close
Sort by
Journal Articles

T Cells Bearing Anti-CD19- and/or Anti-CD38-Chimeric Antigen Receptors Effectively Abrogate Primary Double-Hit Lymphoma Cells

Keichiro Mihara, MD PhD, Tetsumi Yoshida, MD, Yoshifumi Takei, MD PhD, Naomi Sasaki, MD PhD, Yoshihiro Takihara, MD PhD, Tatsuo Ichinohe, MD PhD
Journal: Blood
Blood (2016) 128 (22): 4182.
https://doi.org/10.1182/blood.V128.22.4182.4182
Published: 2016
Journal Articles

All-Trans Retinoic Acid and Interferon-Alpha Increase CD38 Expression on Adult T-Cell Leukemia Cells and Sensitize Them to T Cells Bearing Anti-CD38 Chimeric Antigen Receptors

Keichiro Mihara, MD PhD, Tetsumi Yoshida, MD, Seiko Ishida, MD PhD, Yoshifumi Takei, MD PhD, Akira Kitanaka, MD PhD, Kazuya Shimoda, MD PhD, Kazuhiro Morishita, MD PhD, Yoshihiro Takihara, MD PhD, Tatsuo Ichinohe, MD
Journal: Blood
Blood (2015) 126 (23): 591.
https://doi.org/10.1182/blood.V126.23.591.591
Published: 2015
Journal Articles

Adult T-Cell Leukemia/Lymphoma Cells Were Eliminated By T Cells With Anti-CD38 Chimeric Antigen Receptor Through CD38 Expression Induced By All-Trans Retinoic Acid

Tetsumi Yoshida, MD, Keichiro Mihara, MD, PhD, Akira Kitanaka, MD, PhD, Kazuya Shimoda, MD, PhD, Kazuhiro Morishita, MD, PhD, Yoshihiro Takihara, MD, PhD, Tatsuo Ichinohe, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 1824.
https://doi.org/10.1182/blood.V122.21.1824.1824
Published: 2013